DrugPatentWatch Database Preview
Drugs in Development Information for Celgosivir
» See Plans and Pricing
What is the development status for investigational drug Celgosivir?
Celgosivir is an investigational drug.
There have been 9 clinical trials for Celgosivir.
The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis A, and Hepatitis. The leading clinical trial sponsors are BioWest Therapeutics Inc, Hoechst Marion Roussel, and Singapore General Hospital.
Summary for Celgosivir
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,091 |
| WIPO Patent Applications | 401 |
| Japanese Patent Applications | 225 |
| Clinical Trial Progress | Phase 2 (1969-12-31) |
| Vendors | 16 |
Recent Clinical Trials for Celgosivir
| Title | Sponsor | Phase |
|---|---|---|
| Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore | 60 Degrees Pharmaceuticals LLC | Phase 1/Phase 2 |
| Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore | Duke-NUS Graduate Medical School | Phase 1/Phase 2 |
| Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore | Singapore General Hospital | Phase 1/Phase 2 |
Clinical Trial Summary for Celgosivir
Top disease conditions for Celgosivir
Top clinical trial sponsors for Celgosivir
US Patents for Celgosivir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
